Kamlanoflast

· Inflammasome Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kamlanoflast, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Kamlanoflast In Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]